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Transglutaminases  are a  group of enzymes that  catalyze the covalent conju- 
gation of amines to protein-bound glutamine residues. The products of transglu- 
taminase  activity are  proteins covalently cross-linked by ~-(3"-glutaminyl)-lysine 
isopeptide bonds and proteins containing covalently conjugated polyamines (1- 
6).  Several distinct  intracellular  and extracellular  transglutaminases  have been 
identified  (1,  2).  The  predominant  form  of this  enzyme in  liver and  cultured 
fibroblasts is tissue transglutaminase,  an  ~80,000  D  polypeptide (2,  7-9).  We 
have  measured  the amounts  of this  enzyme  in  a  variety of normal  and  trans- 
formed cell types and have found that macrophages can contain extremely high 
levels (9). 
Studies  from  several  laboratories  have  indicated  that  transglutaminase  may 
play an  important  role  in  macrophage  function.  Activation  of guinea  pig and 
mouse macrophages in vivo is associated with marked increases in transglutami- 
nase activity due to a  dramatic  induction  of tissue transglutaminase  (9-11).  In 
both cell types, elevated levels of transglutaminase activity have been correlated 
with enhanced Fc receptor-mediated phagocytic capacity (10-12). Furthermore, 
several  inhibitors  of transglutaminase  activity  block  phagocytosis  of immune 
complexes and  opsonized erythrocytes (1 1,  12).  However, the  precise  role  of 
transglutaminase  in macrophage function remains to be determined. 
Peripheral blood monocytes can differentiate into macrophages when cultured 
in vitro (13-18).  The differentiation  of myelobastic cells into macrophages has 
been associated with marked increases in the levels of transglutaminase (10,  19). 
Therefore, we were interested in determining the level of tissue transglutaminase 
in peripheral  blood monocytes and  if differentiation  of these cells into macro- 
phages was associated with alterations in the level of the enzyme. We report here 
that  the  levels of tissue transglutaminase  in  freshly  isolated human  peripheral 
blood monocytes are very low but that  the  enzyme accumulates  to significant 
levels during culture of these cells in vitro. 
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Materials and  Methods 
Materials.  Dulbecco's high  glucose minimal essential media (DMEM) 1 was obtained 
from Gibco Laboratories, Grand  Island, NY and was free of endotoxin at the level of 
0.16 ng/ml based on the Limulus amebocyte lysate assay (Associates of Cape Cod, Wood's 
Hole, MA). WI-38 human embryo lung fibroblasts and A431  human epidermoid carci- 
noma cells were obtained from the American Type Culture Collection, Bethesda, MD. 
Human platelets were obtained from whole blood by differential centrifugation. Lipopoi- 
ysaccharide (LPS) B, Escherichia  coli 0111 :B4 was obtained from Difco Laboratories, Inc., 
Detroit, MI. Cycloheximide, N,N-dimethylated casein, and actinomycin D were purchased 
from Calbiochem-Behring Corp., San Diego, CA; Na125I and [3H]dansylcadaverine were 
from Amersham Corp., Arlington Heights, IL. 
Monocyte  Isolation  and Culture.  Heparinized blood was obtained from healthy human 
volunteer donors.  Mononuclear cells were isolated by density gradient centrifugation in 
FicolI-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) or Lymphoprep (Nyegaard, 
Oslo, Norway). The cells were suspended at 10 ×  106 cells/ml in DMEM containing  100 
U/ml penicillin,  100 ~g/ml streptomycin, and  10% heat-inactivated autologous serum.  1 
ml  was  plated  onto  35-mm  Falcon  tissue  culture  dishes  (Becton-Dickinson  Labware, 
Oxnard, CA). After 60 min, nonadherent cells were removed by washing three times with 
DMEM.  The adherent  cells were >90%  monocytes as determined by the  presence of 
granules staining for peroxidase and nonspecific esterase, uptake of latex particles, and 
the presence of Fc and C3 receptors (20). The adherent monocytes then were cultured 
for appropriate times at 37°C in an atmosphere of 5% COs-air. 
For suspension culture on a Teflon-coated surface, mononuclear cells were incubated 
in 60-mm Falcon dishes lined with Teflon FEP,  100  A thick, held in place by a tightly 
fitting Teflon ring  (20).  20  ×  106  mononuclear cells in  8  ml  DMEM  with  10%  heat- 
inactivated autologous serum were placed in each dish. After 3, 6, or 10 d, the suspended 
cells were harvested and the concentration was adjusted to 10 ×  106 cells/ml in DMEM/ 
10% autologous serum.  1 ml was placed in 35-mm Falcon dishes and the adherent cells 
were  isolated as  described  above.  In  both  adherent  and  suspension  cell  cultures,  the 
medium was changed at 3-d intervals. 
Determination of Transglutaminase Activity.  Cultured monocytes were washed three times 
at 37°C with Tris-buffered normal saline (20 mM Tris-HCl, 0.15 M NaCI, pH 7.5) and 
scraped  from  the  dish  in  the  same  buffer  containing  1  mM  EDTA  and  15  mM  /3- 
mercaptoethanol. Cells were disrupted by sonication, and transglutaminase activity in the 
2+  3  lysates was determined by the Ca  -dependent incorporation of [ H]dansylcadaverine into 
dimethylated casein, as described previously (9,  21).  The protein concentration of cell 
lysates was determined by a Coomassie blue binding assay using bovine gamma globulin 
as the standard. 
Immunochemical Detection  of Tissue Transglutaminase.  To detect tissue transglutaminase 
in ceil extracts,  cells were washed,  removed from the dish,  and sonicated as described 
above. Cell lysates were solubilized in 20 mM sodium phosphate, pH 6.8, with 1% sodium 
dodecyl sulfate (SDS), 0.75 M f3-mercaptoethanol, 2.5% sucrose, and 0.001% bromphenol 
blue, and were boiled for 3 min. Solubilized extracts were fractionated by electrophoresis 
on a  6.5%  polyacrylamide gel and electroblotted onto nitrocellulose paper (Schleicher 
and Scheull, Inc., Keene, NH). The paper was neutralized with 5% bovine serum albumin 
and tissue transglutaminase was detected by autoradiography using a monospecific 1251- 
antitransglutaminase antibody (9).  To quantify the amount of tissue transglutaminase in 
cell extracts, the density of the transglutaminase band on autoradiograms was determined 
using a laser densitometer (LKB, Uppsala, Sweden) and compared with standards derived 
from purified guinea pig liver tissue transglutaminase run in parallel lanes on the same 
gel. 
Microscopy.  Cultured  monocytes were photographed using an Olympus IM inverted 
microscope (Olympus Camera Corp., Tokyo, Japan) with phase-contrast optics and Pola- 
roid 084 film (ASA 3000). 
1  Abbreviations used in this paper:  DMEM, Dulbecco's modified essential medium; LPS, bacterial 
lipopolysaccharide; SDS, sodium dodecyl sulfate. 116  TRANSGLUTAMINASE  IN  MONOCYTES 
Results 
Transglutaminase in Freshly  Isolated and Cultured Monocytes.  Cell extracts from 
freshly isolated  monocytes were  fractionated  by  SDS-gel  electrophoresis and 
probed with an  iodinated antibody to tissue transglutaminase. A  single immu- 
noreactive band  was  detected,  possessing  an  electrophoretic mobility  slightly 
slower than purified guinea pig liver transglutaminase (Fig.  1,  lanes  I  and 2). 
The mobility of tissue transglutaminase in monocyte extracts was the same as in 
extracts of other human tissues and cells (Figs.  1, lanes 3-5). Quantitation of the 
amount  of immunoreactive  transglutaminase  in  monocytes by  densitometric 
scanning of autoradiograms indicated that the concentration of enzyme was <20 
ng/mg cell protein. Measurements of enzyme activity in 10 different preparations 
of freshly isolated monocytes gave a value of 0.7 + 0.1 pmol/min/mg cell protein 
(mean +  SEM). 
Adherent culture of human monocytes for up to  10 d  was associated with a 
progressive  and  marked  increase  is  transglutaminase activity (Fig.  2A).  The 
increase in enzyme activity was not linear but accumulated more rapidly after 2- 
3 d  of culture. In the experiments shown in Fig.  2, over a  10-d culture period, 
transglutaminase activity increased 46-fold, from 0.9 to 42 pmol/min/mg. This 
increase m  enzyme activity was not due to activation of preexisting enzyme but 
rather to the accumulation of tissue transg]utaminase in the cells.  As shown in 
Fig.  2B,  extracts of cells  cultured for 4  or  7  d  in  autologous serum showed 
increased levels of tissue transglutaminase (82,000 D) that paralleled the increase 
in enzyme activity. 
There was some variation among donors both in the basal levels of transglu- 
taminase activity and in the pattern of accumulation of the enzyme in cultured 
cells. Fig. 3 demonstrates individual results from 10 different experiments using 
seven different donors. Basal  values of enzyme activity ranged from 0.2 to  1.4 
pmol/min/mg cell protein. After 2 d  of culture in autologous serum, all of the 
FIGURE  1.  Western blots of tissue transglutaminase in human cell extracts, as described in 
Materials and Methods. (Lane 1) 1 ng guinea pig liver tissue transglutaminase, M, =  80,000 
(48 h  exposure); (lane 2) 20 #.g of peripheral blood monocytes cultured 2  d  in autologous 
serum (48 h exposure); (lane 3)  100 t~g of human embryo lung fibroblasts (WI-38 cells,  18 h 
exposure); (lane 4) 50 ~g of human platelets (24 h exposure); and (lane 5)  100 ug of human 
epidermoid carcinoma cells (A431 cells,  18 h exposure). MURTAUGH  ET  AL.  117 
FIGURE 2.  Time  course  of accumulation  of transglutaminase in  cultured  monocytes.  (-4) 
Monocytes were cultured on plastic tissue-culture dishes as described in Materials and Methods. 
At the indicated times, cells were washed, sonicated, and assayed for transglutaminase activity. 
Values  shown  are  the  mean  __.  SEM  of  3-6  determinations  from  individual  dishes.  (B) 
Monocytes attached to plastic tissue<ulture dishes were incubated in  10% autologous serum 
for  1  h  (lane  I),  4  d  (lane 2),  or  7  d  (lane  3).  Samples containing  10 ,~g of protein  were 
subjected to Western blot analysis as described in Materials and Methods. 
10 
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FIGURE 3.  Variable accumulation of transglutaminase activity in cultured human monocytes. 
Monocytes isolated from different donors (n  =  7) and on different occasions (n =  10) were 
assayed for transglutaminase activity immediately or after 48 h of culture in  10% autologous 
serum.  Values shown represent the mean of three determinations on single samples taken 
from individual experiments. 
cell  preparations  showed  increased  levels  of enzyme activity but  some  were 
elevated more than others. The variability in the extent of increase in enzyme 
activity was even more pronounced at later times (data not shown). 
Changes in Morpholog  3' of Cultured  Monocvtes.  The appearance of tissue trans- 
glutaminase was paralleled by a change in the morphology of cultured monocytes. 
Freshly isolated cells  were generally rounded in appearance whereas cells  cul- 1 ] 8  TRANSGLUTAMINASE IN  MONOCYTES 
tured  for 7  d  were spread and  flattened,  with an appearance typical of macro- 
phages. As previously shown, a  50% loss in cell number occurred during the first 
24 h  in culture,  with the cell number remaining constant after this time (20).  In 
the  experiment shown in  Fig.  2A,  the  total protein  increased from  145  #g per 
dish at day 2  to  220 #g per dish at day  10.  Therefore,  the  marked increase in 
transglutaminase specific activity observed over this time period does not reflect 
preferential selection of a subset of monocytes with high levels of enzyme activity. 
Culture  of Monocytes  on  a  Teflon  Surface.  The  degree  of increase  in  tissue 
transglutaminase was dependent on culture conditions.  Cells cultured in Teflon- 
coated dishes,  where adhesion  of cells to substrate  is minimized,  showed much 
less increase in transglutaminase  than did cells cultured  in plastic tissue-cuhure 
dishes (Table I). The level of tissue transglutaminase increased from <10 ng/mg 
cell protein on day 0  to  1,010  ng/mg cell protein on day 10 in cells cultured on 
plastic dishes whereas it increased to only 375 ng/mg cell protein in ceils cultured 
on  Teflon.  Similarly,  the  enzyme activity  increased  ~50-fold  in  the  adherent 
cells but only 20-fold in the cells cultured on Teflon (Table I). The level of tissue 
transglutaminase in  10-d-old cultured cells was 0.1%  of total cellular protein. 
Acceleration  of Transglutaminse Increase by LPS.  LPS induces a variety of differ- 
entiated functions in monocytes and macrophages (22). Culture of paired samples 
of monocytes from an individual donor in media with LPS (1  #g/ml) resulted in 
a  fivefold enhancement  in  the  level  of transglutaminase  activity (Fig.  4).  The 
more rapid  accumulation  of tissue transglutaminase  was observed after both  2 
and  4  d  of culture.  Prolonged  culture  of human  monocytes in  LPS-containing 
media appeared  to decrease cell  viability (data  not  shown) and  so the effect of 
prolonged culture in LPS on enzyme accumulation could not be measured. 
The concentration  range over which LPS was effective is shown in Fig.  5.  In 
TABLE  I 




Transglutaminase activity*  Tissue transglu- 
taminase levels  j 
Plastic  Teflon  Plastic  Teflon 
0  1.2 + 0.3  --  ND  -- 
3  8.3 + 0.3  7.1 + 0.1  100  25 
6  19.6 +  1.6  10.1 + 4.1  550  100 
10  44.8 + 2.4  22.4 + 1.5  1,010  375 
* Adherent  monocytes were cultured  in  DMEM with 10% autologous 
serum in plastic tissue-culture dishes with or without a Teflon lining for 
3, 6, or 10 d. Media was changed at 3-d intervals. Aliquots of mononu- 
clear leukocytes were cultured  in suspension in Teflon-lined tissue cul- 
ture dishes as described in Materials and Methods. Media was changed 
at 3-d intervals. At the indicated intervals, the cells were harvested and 
mononuclear  phagocytes isolated by adhesion  to plastic tissue-culture 
dishes without Teflon for 1 h. 
* Activity is expressed as pmol/min/mg. Values shown represent the mean 
+ SEM of six determinations. 
0 Transglutaminase  levels are expressed as ng/mg cell protein. Data were 
determined  by quantitative  Western blotting as described in Materials 
and Methods. ND, not detectable. MURTAUGH  ET  AL.  119 
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FIGURE 4.  Effect of LPS on the expression of transglutaminase activity in cultured mono- 
cytes. Cells were cultured in 10% autologous serum in the presence (O) or absence (0) of 1 
#g/ml bacterial LPS for varying lengths of time. Values shown represent the mean and SEM 
of six determinations from individual dishes. 
FIGURE 5.  Effect of LPS concentration on the levels of transglutaminase in cultured monc~ 
cytes. (A) Monocytes were collected from four donors and cultured in different concentrations 
of LPS. After 48 h, cells were harvested for determination of transglutaminase activity. Values 
shown represent the mean of six determinations from individual donors. (0, O, A, A) Results 
from four independent experiments using cells obtained from different donors. (B) Western 
blot analysis of the levels of tissue transglutaminase in monocytes after 48-h culture in various 
concentrations of LPS. Each lane contains 20 #g of cell extract from samples shown in A by 
the open circles. 
all donor  cells examined,  10 ng/ml  appeared  to be an optimal concentration  for 
increasing the levels of transglutaminase activity; higher concentrations  of LPS 
were  less effective. As previously noted,  the response  to  LPS appeared  to vary 
among  donors.  Monocytes  that  rapidly  accumulated  transglutaminase  in  the 
absence  of LPS  showed  little further  response  when  LPS  was  included  in  the 
culture media (Fig. 5 A, triangles). Cells that showed less of a  response to culture 120  TRANSGLUTAMINASE  IN  MONOCYTES 
in serum alone were much more sensitive to LPS (Fig. 5A, circles). Western blots 
of LPS-treated  cells with the antitransglutaminase  antibody demonstrated  that 
the  effect  of LPS  on  transglutaminase  activity  in  monocytes  was  due  to  an 
increased  level of the  enzyme and  not  to an activation  of preexisting  enzyme 
(Fig. 5B). 
Induction of Transglutaminase Synthesis in  Cultured Monocytes.  To  define  the 
molecular mechanism underlying the accumulation of tissue transglutaminase  in 
cultured monocytes, the half-life of the enzyme in cells cultured for 2 or 10 d in 
autologous serum  was examined.  After treatment  with cycloheximide, the en- 
zyme in  2-d-old cells possessing low levels of transglutaminase  had a half-life of 
11  h  (Fig.  6).  The half-life of the enzyme was approximately the same (7 h) in 
monocytes cultured for 10 d. 
The finding of increased levels of transglutaminase  in cultured monocytes in 
the absence of a  decrease in the rate of enzyme degradation  indicated that the 
rate  of transglutaminase  synthesis  had  been  increased.  To  determine  if the 
induction of enzyme synthesis was due to increased synthesis of mRNA, mono- 
cytes were treated with actinomycin  D.  To minimize  the times of exposure to 
actinomycin D, cells were cultured for 24 h  in serum-containing  media supple- 
10.0 
0.7  I  I  I  I  ,. 
0  4  8  12  16  20 
Hours after Addition of Cycloheximide 
FIGURE 6.  Transglutaminase activity  in  cultured  monocytes  treated  with  cycloheximide. 
Monocytes  in  plastic  tissue-culture  dishes  were  incubated for  2  (O)  or  10  (O)  d  in  10% 
autologous serum before 50 #M cycloheximide was added to the media. At the indicated times 
after addition of cycloheximide, the cells were removed from the dish and the amount of 
transglutaminase activity was determined.  Values shown represent the mean +  SEM based 
upon six determinations. MURTAUGH  ET  AL.  121 
TABLE  II 






Freshly isolated ceils 
2-d-old monocytes without actinomycin D 
2-d-old monocytes exposed to actinomycin D for 24 h 
pmol/min/mg 
0.5+0.1 
8.2 +  0.3 
1.0 +  0.2 
* Monocytes were cultured 24 h in 10% autologous serum containing 10 
ng/ml LPS.  Cells were then washed and the culture was continued for 
an additional 24 h  in the same media (control) or the same media plus 
actinomycin D (0.5 #g/ml). Data shown are the mean +  SEM from six 
determinations. 
mented with 10 ng/ml LPS. After this preincubation, the cells were cultured for 
an additional 24 h in the presence or absence of actinomycin D (0.5 ttg/ml). This 
level of the drug was sufficient to inhibit [3H]uridine incorporation into RNA by 
95%  (data not shown). As~ shown in Table  II, the transglutaminase activity in 
control cells increased from 0.5  to 8.2  pmol/min/mg cell protein,  whereas in 
actinomycin D-treated cells the enzyme activity was only 1.0 pmol/min/mg cell 
protein.  Western blot analysis showed a  corresponding lack of the enzyme in 
actinomycin D-treated cells (data not shown). 
Discussion 
The results of the studies reported in this paper demonstrate that the level of 
tissue transglutaminase in freshly isolated human monocytes is low, <20 ng per 
mg cell protein. The enzyme increased 50-fold during 10-d culture of the cells 
in autologous serum, reaching 0.1%  of total cell protein.  LPS accelerated the 
accumulation of the enzyme in cultured monocytes. The elevated level of tissue 
transglutaminase in these cells appears to be due to increased gene transcription 
and induction  of enzyme synthesis,  rather than to  enzyme activation or to a 
decreased rate of enzyme degradation. 
We  have  recently reported  (9)  that  culture  of resident  routine  peritoneal 
macrophages in serum-containing media produces a large increase in the levels 
of tissue transglutaminase due to increased transglutaminase gene expression. 
The induction of the enzyme in  human monocytes also appears to involve an 
elevated rate of transglutaminase gene transcription.  However, the pattern of 
enzyme induction in human monocytes is quite different from that in murine 
macrophages.  In  murine macrophages there  is  a  very rapid  induction of the 
enzyme. The level of transglutaminase is increased within 2 h of exposure of the 
cells to serum and can increase 150-fold within 24 h. In cultured monocytes, the 
induction of enzyme synthesis is more gradual, developing over several days, and 
the accumulation of the enzyme is less dramatic than in the macrophages. We 
believe that the induction of transglutaminase in monocytes reflects the differ- 
entiation of these cells into macrophages whereas the induction of the enzyme 
in macrophages is due to a specific activation of transglutaminase gene expres- 122  TRANSGLUTAMINASE IN  MONOCYTES 
sion. 
The induction of tissue transglutaminase in human monocytes appears to be 
linked to in vitro culture of the cells. Culture of peripheral blood monocytes in 
serum-containing media is thought to induce differentiation into macrophages. 
In vitro-derived human macrophages exhibit altered levels of several enzymes, 
including increases in plasma membrane-bound 5'-nucleotidase (13),  lysozyme 
secretion (14), acid phosphatase (14), and plasminogen activator secretion (16), 
and a decrease in lysosomal peroxidase (13). The production of oxygen radicals 
is decreased but can be restored by stimulation with lymphokines or bacterial 
endotoxin (23, 24). Peritoneal macrophages, alveolar macrophages, and Kupffer 
ceils from various animal species have relatively high levels of tissue transgluta- 
minase, 200-1,000 ng/mg cell protein (9, and unpublished observations). There- 
fore, the increased levels of enzyme in the cultured human monocytes may reflect 
their maturation into macrophages. The differentiation of murine myeloblastic 
leukemia cells into macrophages is also associated with a marked accumulation 
of transglutaminase (19). Thus, the induction of tissue transglutaminase may be 
a feature of the terminal differentiation of myelocytic cells into macrophages. 
We have found two experimental manipulations that modulated the rate of 
transglutaminase induction in cultured monocytes. LPS accelerated the induction 
of the enzyme and suspension culture retarded it.  LPS has been reported to 
promote the expression of differentiated functions in macrophages and mono- 
cytes (22, 25-27) and to induce transglutaminase in differentiating myeloblastic 
cells (19). On the other hand, suspension culture has been reported to delay the 
differentiation of monocytes into macrophages (18).  Therefore, the observed 
effects of these manipulations on transglutaminase induction may be secondary 
to the effects on differentiation. 
The function of transglutaminase in monocytes and macrophages is not well 
understood.  It  has  been  suggested that  the enzyme might play a  role in  Fc 
receptor-mediated phagocytosis in macrophages (10-12, 28, 29). The degree of 
phagocytosis  of IgG-coated erythrocytes correlates directly with  the  level of 
enzyme activity in murine macrophages (10), and inhibitors of transglutaminase 
block Fc receptor-mediated phagocytosis in guinea pig peritoneal macrophages 
(11).  Phagocytosis of IgG-coated erythrocytes activates transglutaminase in rat 
peritoneal macrophages (12). Furthermore, transglutaminase can aggregate pu- 
rified Fc receptors from human mononuclear leukocytes, which suggests a role 
for the enzyme in the regulation of Fc receptor function (28). However, the fact 
that freshly isolated monocytes possessing low levels of transglutaminase are fuly 
capable of Fc receptor-mediated phagocytosis (17, 30) indicates that a high level 
of the enzyme is not essential for this activity. Because the capacity of monocytes 
to phagocytose IgG-coated erythrocytes is increased by culture (30), the role of 
transglutaminase in  Fc  receptor-mediated phagocytosis in  monocytes may be 
facilitative rather than essential. In contrast to Fc receptor-mediated phagocy- 
tosis,  interiorization mediated by the complement receptor is  expressed only 
after prolonged culture of human monocytes (17, 30, 31). The induction of this 
activity parallels the induction of tissue transglutaminase, suggesting that  the 
enzyme might play a necessary role in complement receptor-mediated phagocy- 
tosis in monocytes. MURTAUGH  ET  AL.  123 
Summary 
The  levels  and  activity  of tissue  transglutaminase  were  studied  in  human 
peripheral  blood monocytes during  differentiation  into  macrophages  in  vitro. 
The enzyme was present at low levels in freshly isolated monocytes (<20 ng/mg 
cell protein) but increased 50-fold during  10 d of adherent culture in autoiogous 
serum, reaching levels of 0.1% of total cellular protein.  The rate of appearance 
of tissue  transglutaminase  in  monocytes was accelerated  by low levels of lipo- 
polysaccharide. The half-life of disappearance of transglutaminase  from human 
monocytes was 11 and 7 h in 2-d-old and  10-d-old cells, respectively. Treatment 
of 1-day-old monocytes with  actinomycin  D  for  24  h  blocked the  increase  in 
transglutaminase  levels.  These  results  indicated  that  the  induction  of  gene 
transcription and protein synthesis was responsible for the increased transglutam- 
inase levels and activity observed with cultured human monocytes. The induction 
of tissue transglutaminase  may be a component in the in vivo differentiation of 
human monocytes into macrophages. 
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